Carlsmed, Inc. (CARL)
NASDAQ: CARL · Real-Time Price · USD
13.26
-1.15 (-7.98%)
At close: Dec 5, 2025, 4:00 PM EST
13.26
0.00 (-0.02%)
After-hours: Dec 5, 2025, 5:39 PM EST
Carlsmed Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Revenue | 44.75 | 27.17 | 13.78 |
| Revenue Growth (YoY) | 224.82% | 97.16% | - |
| Cost of Revenue | 11.3 | 7.12 | 3.88 |
| Gross Profit | 33.46 | 20.05 | 9.9 |
| Selling, General & Admin | 44.64 | 29.87 | 21.1 |
| Research & Development | 14.77 | 14.3 | 7.4 |
| Operating Expenses | 59.41 | 44.17 | 28.49 |
| Operating Income | -25.95 | -24.12 | -18.59 |
| Interest Expense | -1.48 | -1.32 | -0.64 |
| Interest & Investment Income | 2.08 | 1.33 | 0.33 |
| Other Non Operating Income (Expenses) | -0.39 | -0.14 | - |
| Pretax Income | -25.74 | -24.26 | -18.9 |
| Net Income | -25.74 | -24.26 | -18.9 |
| Preferred Dividends & Other Adjustments | 0.58 | 0.59 | - |
| Net Income to Common | -26.33 | -24.85 | -18.9 |
| Shares Outstanding (Basic) | 9 | 4 | 4 |
| Shares Outstanding (Diluted) | 9 | 4 | 4 |
| Shares Change (YoY) | 120.50% | 4.62% | - |
| EPS (Basic) | -3.07 | -6.11 | -4.86 |
| EPS (Diluted) | -3.07 | -6.11 | -4.86 |
| Free Cash Flow | -28.49 | -25.65 | -17.62 |
| Free Cash Flow Per Share | -3.32 | -6.31 | -4.53 |
| Gross Margin | 74.76% | 73.80% | 71.88% |
| Operating Margin | -57.99% | -88.80% | -134.93% |
| Profit Margin | -58.82% | -91.47% | -137.16% |
| Free Cash Flow Margin | -63.66% | -94.41% | -127.85% |
| EBITDA | -25.73 | -23.98 | -18.46 |
| EBITDA Margin | -57.50% | -88.26% | -133.94% |
| D&A For EBITDA | 0.22 | 0.15 | 0.14 |
| EBIT | -25.95 | -24.12 | -18.59 |
| EBIT Margin | -57.99% | -88.80% | -134.93% |
Source: S&P Capital IQ. Standard template.
Financial Sources.